XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statement of Stockholders' Equity - USD ($)
$ in Thousands
Total
Capital stock
Capital in excess of par value
Retained earnings
Accumulated foreign currency adjustment attributable to parent
Accumulated defined benefit plans adjustment attributable to parent
Accumulated other comprehensive (loss) income
Treasury stock
Balance at the beginning of the year at Dec. 31, 2021   $ 2,689 $ 1,012,526 $ 7,900,113 $ (275,365) $ (195,079)   $ (1,573,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued   6            
Issuance of common stock under employee stock plans     11,966         2,387
Share-based compensation expense     34,587          
Net income $ 852,461     852,461        
Cash dividends paid       (151,635)        
Other       (1)        
Translation adjustments         (225,100)      
Change in long-term intercompany notes         (40,512)      
Net investment hedge instruments gain (loss), net of tax of $(7,126) and $(14,604) for the quarter ended September 30, 2023 and 2022 and $(1,004) and $(34,212) for the nine months ended September 30, 2023 and 2022, respectively         (105,053)      
Amortization of net actuarial loss and other, net of tax of $(518) and $(326) for the quarter ended September 30, 2023 and 2022 and $(1,554) and $(977) for the nine months ended September 30, 2023 and 2022, respectively           3,000    
Purchase of treasury stock               (331,424)
Balance at the end of the year at Sep. 30, 2022 7,132,672 2,695 1,059,079 8,600,938 (435,924) (192,079) $ (628,003) (1,902,037)
Balance at the beginning of the year at Jun. 30, 2022   2,695 1,040,951 8,353,735 (352,851) (193,079)   (1,901,360)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued   0            
Issuance of common stock under employee stock plans     6,068         (632)
Share-based compensation expense     12,060          
Net income 297,641     297,641        
Cash dividends paid       (50,438)        
Other       0        
Translation adjustments         (110,524)      
Change in long-term intercompany notes         (17,393)      
Net investment hedge instruments gain (loss), net of tax of $(7,126) and $(14,604) for the quarter ended September 30, 2023 and 2022 and $(1,004) and $(34,212) for the nine months ended September 30, 2023 and 2022, respectively         44,844      
Amortization of net actuarial loss and other, net of tax of $(518) and $(326) for the quarter ended September 30, 2023 and 2022 and $(1,554) and $(977) for the nine months ended September 30, 2023 and 2022, respectively           1,000    
Purchase of treasury stock               (45)
Balance at the end of the year at Sep. 30, 2022 7,132,672 2,695 1,059,079 8,600,938 (435,924) (192,079) (628,003) (1,902,037)
Balance at the beginning of the year at Dec. 31, 2022 7,476,512 2,700 1,094,236 8,857,485 (368,124) (206,821)   (1,902,964)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued   8            
Issuance of common stock under employee stock plans     18,098         13,731
Share-based compensation expense     35,773          
Net income 970,324     970,324        
Cash dividends paid       (172,693)        
Other       (2)        
Translation adjustments         568      
Change in long-term intercompany notes         (1,091)      
Net investment hedge instruments gain (loss), net of tax of $(7,126) and $(14,604) for the quarter ended September 30, 2023 and 2022 and $(1,004) and $(34,212) for the nine months ended September 30, 2023 and 2022, respectively         (3,083)      
Amortization of net actuarial loss and other, net of tax of $(518) and $(326) for the quarter ended September 30, 2023 and 2022 and $(1,554) and $(977) for the nine months ended September 30, 2023 and 2022, respectively           4,776    
Purchase of treasury stock               (6,578)
Balance at the end of the year at Sep. 30, 2023 8,342,509 2,708 1,148,107 9,655,114 (365,564) (202,045) (567,609) (1,895,811)
Balance at the beginning of the year at Jun. 30, 2023   2,707 1,123,920 9,372,368 (318,359) (203,637)   (1,895,628)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued   1            
Issuance of common stock under employee stock plans     11,274         (129)
Share-based compensation expense     12,913          
Net income 340,370     340,370        
Cash dividends paid       (57,622)        
Other       (2)        
Translation adjustments         (62,092)      
Change in long-term intercompany notes         (6,994)      
Net investment hedge instruments gain (loss), net of tax of $(7,126) and $(14,604) for the quarter ended September 30, 2023 and 2022 and $(1,004) and $(34,212) for the nine months ended September 30, 2023 and 2022, respectively         21,881      
Amortization of net actuarial loss and other, net of tax of $(518) and $(326) for the quarter ended September 30, 2023 and 2022 and $(1,554) and $(977) for the nine months ended September 30, 2023 and 2022, respectively           1,592    
Purchase of treasury stock               (54)
Balance at the end of the year at Sep. 30, 2023 $ 8,342,509 $ 2,708 $ 1,148,107 $ 9,655,114 $ (365,564) $ (202,045) $ (567,609) $ (1,895,811)